In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Guannan Wang, founder of VetOmics, to discuss how comprehensive genomic profiling is advancing precision oncology for dogs. Dr. Wang shares her path from molecular biology research to veterinary cancer genomics, and explains why the field is shifting from "should we use genomics?" to "how do we do it well?" The conversation covers how genomic testing can guide therapy selection, support difficult diagnoses, and help identify true cancer drivers, while emphasizing the importance of real-world outcome follow-up and biomarker-guided combination strategies to improve patient care.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable is joined by Dr. Doug Thamm, Stuart Presidential Chair in Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. Dr. Thamm discusses how naturally occurring cancers in dogs are advancing cancer drug development and informing treatment strategies in both veterinary and human medicine. He shares real-world examples of comparative oncology in action and the role clinical trials play in bringing new therapies to patients. The conversation also explores the challenges of oncology drug development, regulatory pathways, and emerging areas such as biologics, genomic sequencing, and AI-driven tools—offering a clear-eyed view of where veterinary oncology is headed.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Joseph Impellizeri, a true trailblazer in targeted electrochemotherapy and gene electrotransfer immunotherapy. Dr. Impellizeri shares how electroporation-based treatments are transforming cancer care by allowing localized delivery of chemotherapy and immunotherapy with minimal side effects. He discusses how this technology has evolved from treating skin tumors to tackling complex cases like oral, nasal, and even bone cancers — and how it can complement traditional modalities such as surgery, chemotherapy, and radiation. The conversation also explores his groundbreaking work combining gene electrotransfer with PD-1 inhibitors, offering a glimpse into the future of veterinary oncology and more compassionate, targeted treatment options for patients.

📝Transcripts are available at https://www.imprimedicine.com/podcast.

To learn more about ImpriMed Personalized Prediction Profile, please visit https://www.imprimedicine.com/ppp

Music Credit: Hazy by Beat Mekanik